Welter, D. et al. The NHGRI GWAS Catalog, a curated resource of SNP–trait associations. Nucleic Acids Res. 42, 1001–1006 (2014). Cano-Gamez, E. & Trynka, G. From GWAS to function: using functional genomics to identify the mechanisms underlying complex diseases. Front. Genet. 11, 424 (2020). Zappala, Z. & Montgomery, S. B. Non-coding loss-of-function variation in human genomes. Hum. Hered. 81, 78–87 (2016). Adzhubei, I. A. et al. A method and server for predicting damaging missense mutations. Nat. Methods 7, 248–249 (2010). Ioannidis, N. M. et al. REVEL: an ensemble method for predicting the pathogenicity of rare missense variants. Am. J. Hum. Genet. 99, 877–885 (2016). Cheng, J. et al. Accurate proteomewide missense variant effect prediction with AlphaMissense. Science 381, 7492 (2023). Pejaver, V. et al. Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria. Am. J. Hum. Genet. 109, 2163–2177 (2022). Rentzsch, P., Witten, D., Cooper, G. M., Shendure, J. & Kircher, M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 47, 886–894 (2018). Ghandi, M., Lee, D., Mohammad-Noori, M. & Beer, M. A. Enhanced regulatory sequence prediction using gapped k-mer features. PLOS Comput. Biol. 10, e1003711 (2014). Lee, D...

Vellum Biotech Commercializing Nucleic Acid Extraction Method From Roche

Dr. Daniel L. Kastner, former Scientific Director of NHGRI, was a visionary physician-scientist whose discoveries transformed the understanding of innate i

Led by Nicole Lake at Yale School of Medicine, the project will build new models to improve the identification of pathogenic mitochondrial variants.

ASHG in partnership with NHGRI, Biogenand Roche are pleased to recognize this year’s Scholars.

National Institutes of Health (NIH) Director Jay Bhattacharya, M.D., Ph.D., announced the selection of Judy Cho, M.D., as director of NIH’s National Human Genome Research Institute (NHGRI). Dr. Cho jo...